Topical glucocorticoids are a well-known risk factor of intraocular pressure (IOP) elevation in
one third of the general population and in up to 90% of glaucomatous patients. Whether this …

Purpose Starting in 2019, the Global Initiative for Asthma recommended the use of inhaled
corticosteroids (ICS) as part of reliever combination therapy in patients 12 years of age and …

Purpose Guidelines and systematic reviews frequently warn of inhaled corticosteroid (ICS)-
induced glaucoma. However, most of the published studies deny it. Methods We performed …

Objectives: The aim of this study was to investigate the ocular surface, intraocular pressure,
and lens condition in bronchodilator-and steroid-treated chronic pulmonary disease …

Glucocorticoid (GC) therapy is indicated in many diseases, including ocular diseases. An
important side-effect of GC therapy is GC-induced ocular hypertension (GIOHT), which may …

Abstract Background Inhaled corticosteroids (ICSs) effectively deliver corticosteroids to
target sites in the lungs and reduce systemic effects compared with oral corticosteroids, but …

Purpose: To evaluate retinal nerve fiber layer thickness (RNFLT), ganglion cell layer
thickness (GCLT), subfoveal choroidal thickness (SFCT), and central retinal thickness (CRT) …

Background The purpose of this review was to evaluate the consistency of central corneal
thickness (CCT) values reported with use of Topcon SP-2000 P and SP-3000 P non-contact …

The OTC placement of intranasal steroid may cause a subset of genetically sensitive
individuals to earlier development of IOP and ILO, but the socioeconomic benefit for patients …

Purpose Corticosteroids are under suspicion of playing an important role in the development
of retinopathy. We aimed to determine peripapillary retinal nerve fiber layer (RNFL) thinning …